These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
194 related articles for article (PubMed ID: 12751676)
1. Common transfusion-transmitted infectious agents among thalassaemic children in Bangladesh. Mollah AH; Nahar N; Siddique MA; Anwar KS; Hassan T; Azam MG J Health Popul Nutr; 2003 Mar; 21(1):67-71. PubMed ID: 12751676 [TBL] [Abstract][Full Text] [Related]
2. Prevalence and risk factors of hepatitis C virus, hepatitis B virus, and human immunodeficiency virus in multiply transfused recipients in Mexico. Calderón GM; González-Velázquez F; González-Bonilla CR; Novelo-Garza B; Terrazas JJ; Martínez-Rodríguez ML; Cortés-Márquez SR; Blanco-Flores JP; Rodríguez-Rodríguez A; Del Campo MA; Cortés-Gómez R; Mejía-Bocanegra MG Transfusion; 2009 Oct; 49(10):2200-7. PubMed ID: 19538543 [TBL] [Abstract][Full Text] [Related]
3. High prevalence of occult hepatitis B in hepatitis C-infected Egyptian children with haematological disorders and malignancies. Said ZN; El-Sayed MH; El-Bishbishi IA; El-Fouhil DF; Abdel-Rheem SE; El-Abedin MZ; Salama II Liver Int; 2009 Apr; 29(4):518-24. PubMed ID: 19192168 [TBL] [Abstract][Full Text] [Related]
4. Risks of seroconversion of hepatitis B, hepatitis C and human immunodeficiency viruses in children with multitransfused thalassaemia major. Lee WS; Teh CM; Chan LL J Paediatr Child Health; 2005; 41(5-6):265-8. PubMed ID: 15953326 [TBL] [Abstract][Full Text] [Related]
5. Prevalence of hepatitis B, C, and delta virus infections among children in Mongolia: progress in childhood immunization. Tsatsralt-Od B; Takahashi M; Endo K; Agiimaa D; Buyankhuu O; Ninomiya M; Lorenzo FR; Okamoto H J Med Virol; 2007 Aug; 79(8):1064-74. PubMed ID: 17596839 [TBL] [Abstract][Full Text] [Related]
6. Residual risk of transfusion-transmitted human immunodeficiency virus, hepatitis C virus, and hepatitis B virus infections in Italy. Gonzalez M; Règine V; Piccinini V; Vulcano F; Giampaolo A; Hassan HJ Transfusion; 2005 Oct; 45(10):1670-5. PubMed ID: 16181219 [TBL] [Abstract][Full Text] [Related]
7. Anti-hepatits B core antigen testing, viral markers, and occult hepatitis B virus infection in Pakistani blood donors: implications for transfusion practice. Bhatti FA; Ullah Z; Salamat N; Ayub M; Ghani E Transfusion; 2007 Jan; 47(1):74-9. PubMed ID: 17207233 [TBL] [Abstract][Full Text] [Related]
8. Seroprevalence of hepatitis B, hepatitis C, CMV and HIV in multiply transfused thalassemia patients: results from a thalassemia day care center in Malaysia. Jamal R; Fadzillah G; Zulkifli SZ; Yasmin M Southeast Asian J Trop Med Public Health; 1998 Dec; 29(4):792-4. PubMed ID: 10772566 [TBL] [Abstract][Full Text] [Related]
10. Use of replacement blood donors to study the epidemiology of major blood-borne viruses in the general population of Maputo, Mozambique. Cunha L; Plouzeau C; Ingrand P; Gudo JP; Ingrand I; Mondlane J; Beauchant M; Agius G J Med Virol; 2007 Dec; 79(12):1832-40. PubMed ID: 17935167 [TBL] [Abstract][Full Text] [Related]
11. Immunogenicity of hepatitis B vaccine in multi-transfused thalassemic patients with and without hepatitis C infection: a comparative study with healthy controls. Froutan-Pishbijari H; Ghofrani H; Mirmomenm S; Kazemi-Asl S; Nassiri-Toosi M; Farahvash MJ; Toroghi HH; Aminian K; Mansour-Ghanaei F; Bagherzadeh AH Med Sci Monit; 2004 Dec; 10(12):CR679-83. PubMed ID: 15567986 [TBL] [Abstract][Full Text] [Related]
12. Prevalence of antibodies against hepatitis C virus and hepatitis B coinfection in healthy population in Bulgaria. A seroepidemiological study. Atanasova MV; Haydouchka IA; Zlatev SP; Stoilova YD; Iliev YT; Mateva NG Minerva Gastroenterol Dietol; 2004 Mar; 50(1):89-96. PubMed ID: 15719010 [TBL] [Abstract][Full Text] [Related]
14. Current trends of seroprevalence of transfusion transmitted infections in Pakistani β-thalassaemic patients. Sultan S; Irfan SM; Siddiqui M; Zaidi SM Malays J Pathol; 2016 Dec; 38(3):251-255. PubMed ID: 28028295 [TBL] [Abstract][Full Text] [Related]
15. Prevalence of anti HCV, HBsAg and HIV antibodies in high risk recipients of blood and blood products. Chakrabarti S; Pradhan P; Roy A; Hira M; Bandyopadhyay G; Bhattacharya DK Indian J Public Health; 2006; 50(1):43-4. PubMed ID: 17193761 [TBL] [Abstract][Full Text] [Related]
16. Frequencies of hepatitis B, delta and human immune deficiency virus markers in multitransfused Saudi patients with thalassaemia and sickle-cell disease. el-Hazmi MA; Ramia S J Trop Med Hyg; 1989 Feb; 92(1):1-5. PubMed ID: 2918572 [TBL] [Abstract][Full Text] [Related]
18. Prevalence of HBV, HCV, HIV-1, 2 and HTLV-I/II infections among blood donors in a teaching hospital in the Central region of Saudi Arabia. El-Hazmi MM Saudi Med J; 2004 Jan; 25(1):26-33. PubMed ID: 14758374 [TBL] [Abstract][Full Text] [Related]
19. [Investigation of hemodialysis patients in terms of the presence of occult hepatitis B]. Altindiş M; Uslan I; Cetinkaya Z; Yüksel S; Ciftçi IH; Demirtürk N; Ozdemir M; Arslan F; Aktepe OC Mikrobiyol Bul; 2007 Apr; 41(2):227-33. PubMed ID: 17682709 [TBL] [Abstract][Full Text] [Related]
20. Prevalence of occult hepatitis B & C in HIV patients infected through sexual transmission. Rai RR; Mathur A; Mathur D; Udawat HP; Nepalia S; Nijhawan S; Mathur A Trop Gastroenterol; 2007; 28(1):19-23. PubMed ID: 17896605 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]